Key TakeawaysMajor U.S. stock indices closed higher, with the Dow Jones up 0.15%, the S&P 500 gaining 0.31%, and the Nasdaq leading the rally with a 0.70% increase.Pfizer (PFE) received early U.S. Federal Trade Commission (FTC) clearance for its Metsera acquisition, a crucial step forward in its strategy to enter the rapidly growing obesity drug market.Johnson & Johnson (JNJ) submitted an application to the U.S. FDA for Stelara® (ustekinumab) for the treatment of pediatric ulcerative colitis, aiming to expa ...

Eli Lilly reported higher third-quarter profit and raised its full-year outlook on the back of surging demand for its GLP-1 weight-loss drugs https://t.co/coJ3Y93LzK ...

Eli Lilly raises its full-year guidance as revenue from its blockbuster weight loss and diabetes drugs beat analysts’ estimates in the third quarter https://t.co/MdyjurUDYZ ...

The FDA announced the first drug manufacturers that will receive expedited reviews as part of a new initiative to reward companies for acquiescing to the Trump administration’s stated policy priorities https://t.co/Jl2T5Lb28l ...

AstraZeneca got a rare sell rating on Thursday as Deutsche Bank analysts downgraded the British drugmaker, taking a more skeptical view on the company’s drug pipeline, in particular for breast cancer treatments https://t.co/ursBCWKI2p ...

Astroenica, the largest pharmaceutical manufacturer in the United Kingdom, is committing to offer Americans major discounts on their vast catalog of prescription drugs. One of the great companies, by the way, and a most favored nation's pricing clause. So, most favored nation is uh you're going to pay whatever the lowest price anywhere in the world is.That's what you're going to be paying. ...

Big Pharma is cutting investment in the UK as the government plays hardball with drugmakers over pricing, writes Matthew Brooker (via @opinion) https://t.co/yJo7zDj9qs ...

Indian firms are gearing up to supply the basic ingredient that goes in making copies of Novo's weight-loss drugs https://t.co/htCapzPlkP ...

British drugmaker GSK Plc pledged to invest $30 billion in the US over the next five years, making the announcement as President Donald Trump arrives in the UK for a highly anticipated state visit https://t.co/HkyI54iRBe ...

US regulators issued a flurry of letters calling out pharmaceutical companies for allegedly misleading ads https://t.co/nDUos3cssQ ...